PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Becton, Dickinson and Company, BD Life Sciences-Integrated Diagnostic Solutions, Sparks, Maryland, USA.\', \'CTMD Research, Palm Springs, Florida, USA.\', \'Fellows Research Alliance, Inc., Savannah, Georgia, USA.\', \'Comprehensive Clinical Research, LLC, West Palm, Florida, USA.\', \'William Beaumont Hospital, Royal Oak, Michigan, USA.\', \'BioCollections Worldwide, Inc., Miami, Florida, USA.\', \'Johns Hopkins University School of Medicine, Department of Pathology, Division of Medical Microbiology, Baltimore, Maryland, USA.\', \'Tricore Reference Laboratory, Albuquerque, New Mexico, USA.\', \'NorthShore University Health System, Department of Pathology and Laboratory Medicine, Evanston, Illinois, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/JCM.01019-21
?:hasPublicationType
?:journal
  • Journal of clinical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 34586894
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.256
?:rankingScore_hIndex
  • 226
?:title
  • Performance Evaluation of the BD SARS-CoV-2 Reagents for the BD MAX System.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all